Highlights
The global Crohn鈥檚 Disease Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Crohn鈥檚 Disease Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Crohn鈥檚 Disease Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Crohn鈥檚 Disease Drug include AbbVie, Janssen Biotech, Amgen, Tillotts Pharma and Takeda Pharmaceuticals, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Crohn鈥檚 Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn鈥檚 Disease Drug.
The Crohn鈥檚 Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Crohn鈥檚 Disease Drug market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crohn鈥檚 Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
AbbVie
Janssen Biotech
Amgen
Tillotts Pharma
Takeda Pharmaceuticals
Segment by Type
Aminosalicylates (5-ASA)
Corticosteroids
Immunomodulators
Antibiotics
Segment by Application
Achieving Remission (The Absence Of Symptoms)
Maintaining Remission (Prevention Of Flare-Ups)
Pediatric Crohn'S Disease
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Crohn鈥檚 Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Crohn鈥檚 Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Crohn鈥檚 Disease Drug 麻豆原创 Overview
1.1 Product Overview and Scope of Crohn鈥檚 Disease Drug
1.2 Crohn鈥檚 Disease Drug Segment by Type
1.2.1 Global Crohn鈥檚 Disease Drug 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Aminosalicylates (5-ASA)
1.2.3 Corticosteroids
1.2.4 Immunomodulators
1.2.5 Antibiotics
1.3 Crohn鈥檚 Disease Drug Segment by Application
1.3.1 Global Crohn鈥檚 Disease Drug 麻豆原创 Value by Application: (2023-2029)
1.3.2 Achieving Remission (The Absence Of Symptoms)
1.3.3 Maintaining Remission (Prevention Of Flare-Ups)
1.3.4 Pediatric Crohn'S Disease
1.4 Global Crohn鈥檚 Disease Drug 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Crohn鈥檚 Disease Drug Revenue 2018-2029
1.4.2 Global Crohn鈥檚 Disease Drug Sales 2018-2029
1.4.3 Global Crohn鈥檚 Disease Drug 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Crohn鈥檚 Disease Drug 麻豆原创 Competition by Manufacturers
2.1 Global Crohn鈥檚 Disease Drug Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Crohn鈥檚 Disease Drug Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Crohn鈥檚 Disease Drug Average Price by Manufacturers (2018-2023)
2.4 Global Crohn鈥檚 Disease Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Crohn鈥檚 Disease Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Crohn鈥檚 Disease Drug, Product Type & Application
2.7 Crohn鈥檚 Disease Drug 麻豆原创 Competitive Situation and Trends
2.7.1 Crohn鈥檚 Disease Drug 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Crohn鈥檚 Disease Drug Players 麻豆原创 Share by Revenue
2.7.3 Global Crohn鈥檚 Disease Drug 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Crohn鈥檚 Disease Drug Retrospective 麻豆原创 Scenario by Region
3.1 Global Crohn鈥檚 Disease Drug 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Crohn鈥檚 Disease Drug Global Crohn鈥檚 Disease Drug Sales by Region: 2018-2029
3.2.1 Global Crohn鈥檚 Disease Drug Sales by Region: 2018-2023
3.2.2 Global Crohn鈥檚 Disease Drug Sales by Region: 2024-2029
3.3 Global Crohn鈥檚 Disease Drug Global Crohn鈥檚 Disease Drug Revenue by Region: 2018-2029
3.3.1 Global Crohn鈥檚 Disease Drug Revenue by Region: 2018-2023
3.3.2 Global Crohn鈥檚 Disease Drug Revenue by Region: 2024-2029
3.4 North America Crohn鈥檚 Disease Drug 麻豆原创 Facts & Figures by Country
3.4.1 North America Crohn鈥檚 Disease Drug 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Crohn鈥檚 Disease Drug Sales by Country (2018-2029)
3.4.3 North America Crohn鈥檚 Disease Drug Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Crohn鈥檚 Disease Drug 麻豆原创 Facts & Figures by Country
3.5.1 Europe Crohn鈥檚 Disease Drug 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Crohn鈥檚 Disease Drug Sales by Country (2018-2029)
3.5.3 Europe Crohn鈥檚 Disease Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Crohn鈥檚 Disease Drug 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Crohn鈥檚 Disease Drug 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Crohn鈥檚 Disease Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Crohn鈥檚 Disease Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Crohn鈥檚 Disease Drug 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Crohn鈥檚 Disease Drug 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Crohn鈥檚 Disease Drug Sales by Country (2018-2029)
3.7.3 Latin America Crohn鈥檚 Disease Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Crohn鈥檚 Disease Drug 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Crohn鈥檚 Disease Drug 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Crohn鈥檚 Disease Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Crohn鈥檚 Disease Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Crohn鈥檚 Disease Drug Sales by Type (2018-2029)
4.1.1 Global Crohn鈥檚 Disease Drug Sales by Type (2018-2023)
4.1.2 Global Crohn鈥檚 Disease Drug Sales by Type (2024-2029)
4.1.3 Global Crohn鈥檚 Disease Drug Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Crohn鈥檚 Disease Drug Revenue by Type (2018-2029)
4.2.1 Global Crohn鈥檚 Disease Drug Revenue by Type (2018-2023)
4.2.2 Global Crohn鈥檚 Disease Drug Revenue by Type (2024-2029)
4.2.3 Global Crohn鈥檚 Disease Drug Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Crohn鈥檚 Disease Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Crohn鈥檚 Disease Drug Sales by Application (2018-2029)
5.1.1 Global Crohn鈥檚 Disease Drug Sales by Application (2018-2023)
5.1.2 Global Crohn鈥檚 Disease Drug Sales by Application (2024-2029)
5.1.3 Global Crohn鈥檚 Disease Drug Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Crohn鈥檚 Disease Drug Revenue by Application (2018-2029)
5.2.1 Global Crohn鈥檚 Disease Drug Revenue by Application (2018-2023)
5.2.2 Global Crohn鈥檚 Disease Drug Revenue by Application (2024-2029)
5.2.3 Global Crohn鈥檚 Disease Drug Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Crohn鈥檚 Disease Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Crohn鈥檚 Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Crohn鈥檚 Disease Drug Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Janssen Biotech
6.2.1 Janssen Biotech Corporation Information
6.2.2 Janssen Biotech Description and Business Overview
6.2.3 Janssen Biotech Crohn鈥檚 Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Janssen Biotech Crohn鈥檚 Disease Drug Product Portfolio
6.2.5 Janssen Biotech Recent Developments/Updates
6.3 Amgen
6.3.1 Amgen Corporation Information
6.3.2 Amgen Description and Business Overview
6.3.3 Amgen Crohn鈥檚 Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Amgen Crohn鈥檚 Disease Drug Product Portfolio
6.3.5 Amgen Recent Developments/Updates
6.4 Tillotts Pharma
6.4.1 Tillotts Pharma Corporation Information
6.4.2 Tillotts Pharma Description and Business Overview
6.4.3 Tillotts Pharma Crohn鈥檚 Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Tillotts Pharma Crohn鈥檚 Disease Drug Product Portfolio
6.4.5 Tillotts Pharma Recent Developments/Updates
6.5 Takeda Pharmaceuticals
6.5.1 Takeda Pharmaceuticals Corporation Information
6.5.2 Takeda Pharmaceuticals Description and Business Overview
6.5.3 Takeda Pharmaceuticals Crohn鈥檚 Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Takeda Pharmaceuticals Crohn鈥檚 Disease Drug Product Portfolio
6.5.5 Takeda Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Crohn鈥檚 Disease Drug Industry Chain Analysis
7.2 Crohn鈥檚 Disease Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Crohn鈥檚 Disease Drug Production Mode & Process
7.4 Crohn鈥檚 Disease Drug Sales and 麻豆原创ing
7.4.1 Crohn鈥檚 Disease Drug Sales Channels
7.4.2 Crohn鈥檚 Disease Drug Distributors
7.5 Crohn鈥檚 Disease Drug Customers
8 Crohn鈥檚 Disease Drug 麻豆原创 Dynamics
8.1 Crohn鈥檚 Disease Drug Industry Trends
8.2 Crohn鈥檚 Disease Drug 麻豆原创 Drivers
8.3 Crohn鈥檚 Disease Drug 麻豆原创 Challenges
8.4 Crohn鈥檚 Disease Drug 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
AbbVie
Janssen Biotech
Amgen
Tillotts Pharma
Takeda Pharmaceuticals
听
听
*If Applicable.